Answers are grounded in this paper and cite their sources.
Thoracic duct lymphocyte depletion, a technique that selectively suppresses cellular immune defenses, was performed in a patient with myasthenia gravis. The patient demonstrated a 70% reduction in anticholinesterase medication requirement. These data lend further support to the apparent relationship between myasthenia gravis, the thymus, and cell-mediated immunity and implicate the lymphocyte, or a substance bound to it, as a contributing factor in myasthenia gravis.
No takes yet. Share an insight, caveat, or question.
Tindall et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: